Radiomics strategy for glioma grading using texture features from multiparametric MRI

Qiang Tian, Lin‐Feng Yan, Xi Zhang, +17

Journal of Magnetic Resonance Imaging

Structural and advanced imaging in predicting MGMT promoter methylation of primary glioblastoma: a region of interest based analysis

Yu Han, Lin‐Feng Yan, Xibin Wang, +14

BMC Cancer

LncRNA NEAT1/microRNA-129-5p/SOCS2 axis regulates liver fibrosis in alcoholic steatohepatitis

Junfeng Ye, Yuanqiang Lin, Ying Yu, +1

Journal of Translational Medicine

Disturbed neurovascular coupling in type 2 diabetes mellitus patients: Evidence from a comprehensive fMRI analysis

Bo Hu, Lin‐Feng Yan, Qian Sun, +16

NeuroImage Clinical

Intravoxel incoherent motion diffusion-weighted MR imaging of gliomas: efficacy in preoperative grading

Yu‐Chuan Hu, Lin‐Feng Yan, Lang Wu, +10

Scientific Reports

Ginsenoside Rb1 Attenuates Oxygen-Glucose Deprivation-Induced Apoptosis in SH-SY5Y Cells via Protection of Mitochondria and Inhibition of AIF and Cytochrome c Release

Jianmin Liang, Ying Yu, Bin Lü, +3

Molecules

Lipid PeroxidationApoptosisCell DeathRedox BiologyGinsenoside Rb1 +16

Alterations of White Matter Integrity and Hippocampal Functional Connectivity in Type 2 Diabetes Without Mild Cognitive Impairment

Qian Sun, Guanqun Chen, Xibin Wang, +12

Frontiers in Neuroanatomy

Neurovascular decoupling in type 2 diabetes mellitus without mild cognitive impairment: Potential biomarker for early cognitive impairment

Ying Yu, Lin‐Feng Yan, Qian Sun, +15

NeuroImage

Alzheimer's DiseaseVascular Cognitive DisorderDementiaDiabetesType 2 +8

Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial

Zhicheng Liu, Lin‐Feng Yan, Yu‐Chuan Hu, +7

BMC Medical Imaging

Combination of EP ₄ antagonist MF-766 and anti-PD-1 promotes anti-tumor efficacy by modulating both lymphocytes and myeloid cells

Yun Wang, Long Cui, Peter Georgiev, +25

OncoImmunology